TELADOC (TDOC) - Holzer & Holzer

ATLANTA, GA – – (Newsfile Corp. – April 28, 2022) – – Holzer & Holzer, LLC is investigating whether Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC) complied with federal securities laws. On April 27, 2022, Teladoc reported first quarter financial results for the quarter ended March 31, 2022. The Company announced it was revising and lowering its 2022 outlook due to a “lower-than-expected yield” on the Company’s marketing spend and a net loss per share of $41.58, which was attributed to a “non-cash goodwill impairment charge of $6.6 billion.” Following this announcement, the Company’s stock price dropped. If you purchased Teladoc stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  cholzer@holzerlaw.com  or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com to discuss your legal rights.

View Complaint

View Representation Agreement

Provide Your Information To Take Action

Name*
First Last
Email*
Phone*
Address*
Street Address Address Line 2 City State / Province / Region ZIP / Postal Code Country
Shares Purchased:*
Date Purchased Number of Shares Acquired Acquisition Price Per Share
Shares Sold:
Date Sold Number of Shares Sold Selling Price Per Share
By clicking on the button below, I intend to sign and execute this Agreement and retain Holzer & Holzer, LLC to proceed on my behalf.*
- I agree.
Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.
Signature*
CAPTCHA

Date Purchased	Number of Shares Acquired	Acquisition Price Per Share